This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.






  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Oct. 13, 2011

Home   About   Membership   Continuing Education   Journal   Online Store   Contact Us


Avanir Pharmaceuticals

AVANIR Pharmaceuticals, Inc. is focused on commercializing novel therapeutic products.

 

New way to gain a clear view of the brain
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A group of Japanese neuroscientists is trying to peer into the mind — literally. They have devised a way to turn the brain’s opaque gray matter into a glassy, see-through substance. The group, based at the government-financed Riken Brain Science Institute in Wako, Japan, has created an inexpensive chemical cocktail that transforms dead biological tissue from a colored mass into what looks like translucent jelly. Soaking brain tissue in the solution makes it easier for neuroscientists to see what’s inside — a step they hope will uncover the physical basis of personality traits, memories and even consciousness. More



Tell AANN your thoughts
American Association of Neuroscience Nurses    Share    Share on FacebookTwitterShare on LinkedinE-mail article
AANN wants to hear from you! Please take a few minutes to respond to the AANN membership survey before 5 p.m. CST on Friday, Oct. 14. Your responses will help AANN leadership make decisions about benefits, services, educational programs and products, and more in the coming year. Leave your name and email information at the end of the survey to be entered into a drawing to win one of four $50 Visa gift cards or one of 10 Starbucks gift cards. Thank you for your interest in your association! More

Brain linked to robotic hand; success hailed
Pittsburgh Post-Gazette    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBrief
When it happened, emotions flashed like lightning. The nearby robotic hand that Tim Hemmes was controlling with his mind touched his girlfriend Katie Schaffer's outstretched hand. One small touch for Hemmes; one giant reach for people with disabilities.
More



Brain memory finding may help schizophrenia research
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A variation in a part of the brain may explain why some people have a better memory of reality than others and could advance understanding of brain disorders like schizophrenia. In a study scheduled to be published in the Journal of Neuroscience, researchers from Cambridge University tested 53 volunteers and found differences in their ability to distinguish between real or imagined memories. The scientists then found a direct link between these results and the size of a specific area of the brain called the paracingulate sulcus, or PCS. More

Certain after-stroke treatments may boost outcome
HealthDay News via U.S. News & World Report    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Stroke patients function better physically and are less likely to die if they undergo treatment that pays special attention to fever, high blood sugar and swallowing problems, new research suggests. More

Clumps of rogue Parkinson's proteins spread to new neurons and seed more clumps
Discover Magazine    Share    Share on FacebookTwitterShare on LinkedinE-mail article
There are many things you don't want gathering in large numbers, including locusts, rioters, and brain proteins. Our nerve cells contain many proteins that typically live in solitude, but occasionally gather in their thousands to form large insoluble clumps. These clumps can be disastrous. They can wreck neurons, preventing them from firing normally and eventually killing them. Such clumps are the hallmarks of many brain diseases. The neurons of Alzheimer's patients are riddled with tangles of a protein called tau. Those of Parkinson's patients contain bundles, or fibrils, of another protein called alpha-synuclein. More

Drug may reduce plaque in brains of Alzheimer's patients
WebMD    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A small study shows that a new drug being tested for the treatment of Alzheimer's disease reduces the buildup of plaques in the brain associated with the fatal disease. The experimental compound, known as gantenerumab, is being developed by Roche, the Swiss pharmaceutical company. More

Electrical stimulation creates images that could help blind see
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Even when vision has failed, the mind's eye can see, given just the right voltage to just the right place in the brain, says a study published in the Proceedings of the National Academy of Sciences. The study, which used rhesus monkeys with intact vision, demonstrated one way to restore something akin to sight in the blind. It showed that direct stimulation to the brain's visual cortex can create the perception of shapes, colors and contrasts — even when the eyes cannot see them. More

Kids' emergency room concussion visits up 60 percent over decade
The Associated Press via The Gainesville Sun    Share    Share on FacebookTwitterShare on LinkedinE-mail
article
The number of athletic children going to hospitals with concussions is up 60 percent in the past decade, a finding that is likely due to parents and coaches being more careful about treating head injuries, according to a new federal study. More

Statins protect brain in head trauma
Medpage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Statins may make traumatic brain injury much more survivable for older adults, a national study suggested. Seniors on a statin at the time of moderate-to-severe head trauma were 76 percent less likely to die in hospital. More

Study: Daily aspirin could up risk of macular degeneration for elderly
The Huffington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Elderly people who regularly take aspirin could have an increased risk of age-related sight problems, according to a new study. The research, conducted by researchers from all over Europe, shows that people who take aspirin twice a day have a doubled risk of having advanced age-related macular degeneration, compared with people who don't regularly take aspirin. However, the risk is still relatively low. More

Treatment of trauma to brain is studied
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Techniques being used to treat psychological lapses from traumatic brain injuries, the signature wounds suffered by troops in Iraq and Afghanistan, appear to be helpful, but lack rigorous scientific support, a government-appointed panel reported after completing the most comprehensive analysis of the evidence to date. More


 
AANN Neuroscience News
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Brie Ragland, Content Editor, 469.420.2639   
Contribute news

This edition of the AANN Neuroscience News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Oct. 6, 2011
Sept. 29, 2011
Sept. 22, 2011
Sept. 15, 2011



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063